Login

Securities are offered through IFP Securities, LLC, while AmeriCorps' CEO shares key remarks in a separate discussion. 00:10:00

Share On Facebook Share On Twitter

William Hamm, CFA, CFP®, CLU. Chief Executive Officer 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Our Values In Our Colleagues’ Words | William Blair Investment Management
00:10:00
SNNLive interviewed Shaun Maine, CEO, and John Flores, Executive Vice President of Converge Technology Solutions Corp.|Shaun Maine is the Group CEO of Converge Technology Solutions.
00:10:00
Klaas U Webinar: Social Security and Your Retirement Income Benefits Explained | Eric Schwartz - Investment Adviser Representative of Klaas Financial
00:10:00
Eileen P. Drake Presents at Gabelli Funds Aerospace & Defense Symposium 2022 | Eileen P Drake - CEO of aerojet rocketdyne holdings inc
00:10:00
committed to investing patiently in developing new ways to live eat travel and build|Bill Gates,Founder,Breakthrough Energy Ventures
00:10:00
Verb CEO Rory Cutaia discusses business and technology on It's Your Money with Jo Ann Morgano and Martin Saltzman.
00:10:00
Strategies for Identifying Investment Opportunities Amid Market Volatility | Ali Dibadj , CEO , Janus Henderson.
00:00:00
Adelene Pewrkins, CEO, Infinity Pharmaceuticals Inc
00:10:00
Norway: Leading the Charge Towards Electric Vehicle Adoption|Ragnhild Syrstad,State Secretary,Norway
00:10:00
Dr. Andrew Tunks on Meteoric Resources' Cobalt Ventures: Unveiling Canada's Riches
00:10:00
Venture Capital and Open Source the Good the Bad|Michael Yamnitsky,Managing Director,Insight Partners
00:10:00
Gold Market Outlook: Navigating Macro Forces and Fed Policy Expectations

© 2017 - Neuhu+